Podchaser Logo
Home
Incidence of autoimmune rheumatic diseases following exposure to diabetes and weight loss medications

Incidence of autoimmune rheumatic diseases following exposure to diabetes and weight loss medications

Released Thursday, 25th April 2024
Good episode? Give it some love!
Incidence of autoimmune rheumatic diseases following exposure to diabetes and weight loss medications

Incidence of autoimmune rheumatic diseases following exposure to diabetes and weight loss medications

Incidence of autoimmune rheumatic diseases following exposure to diabetes and weight loss medications

Incidence of autoimmune rheumatic diseases following exposure to diabetes and weight loss medications

Thursday, 25th April 2024
Good episode? Give it some love!
Rate Episode

In this episode of Arthritis At Home, we are sharing the #CRArthritis interview with Dr. Derin Karacabeyli, rheumatology resident at the University of British Columbia. Dr. Karacabeyli is studying the effects of treating metabolic comorbidities like obesity and type 2 diabetes on patients with immune-mediated inflammatory diseases. In this interview, he shares the work he is conducting to look at the potential risks and benefits for inflammatory arthritis patients taking a new class of medications used in type 2 diabetes therapy.

Additional learning resources

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features